Personal stories

Recognizing myopia as a public health problem, the Chinese government launched a comprehensive national plan for the prevention and control of myopia. Village doctors like Pan Taoling have a large role to play in achieving the government’s goals.

For International Day of Persons with Disabilities, we’re celebrating how the company has committed to being a safe space for people with diverse physical, neurological and mental health abilities—and sees them as crucial business assets.

Health-related impact investments remain limited, even as the field now totals a $715 billion global market. J&J Impact Ventures, an investment fund within the J&J Foundation, is investing in purpose-driven entrepreneurs and their startups in the belief that as their businesses grow, so will their impact.

Check out this infographic breakdown of the company’s third-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Devices businesses.

The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.

Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.

Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.

The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he’s a Nobel Laureate. Learn about the transformational research that’s led to these well-deserved scientific accolades.

Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.